SAGINAW, Mich.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/NPN?src=hash" target="_blank"gt;#NPNlt;/agt;–Graminex® L.L.C., producer of Graminex®
Non-Solvent Flower Pollen Extracts™, receives Health Canada Approval
under the Natural and Non-prescription Health Products Directorate
(NNHPD) for its PollenBerry® Flower Pollen Extract™.
PollenBerry® is a proprietary formulation containing Graminex®
G60® Flower Pollen Extract™ and Cranberry Powder.
Health Canada’s certification guarantees that Graminex Products meet the
highest quality standards according to the guidelines of Health Canada’s
Health Products and Food Branch’s Mandate. The mandated guidelines take
an integrated approach to managing the risks and benefits in regards to
supplements and health food, safeguarding the consumer against inferior
products.
“With the addition of PollenBerry®, Graminex® now
has three finished goods approved by Health Canada’s NNHPD with the
associated NPN numbers. We are happy to offer this newest product to our
customers,” stated Justin E. Ritter, Regulatory Affairs.
PollenBerry® has been approved for use as a traditional and
herbal medicine with Graminex’s newest NPN license. The recommended use
for PollenBerry® approved under this NPN is to help prevent
(recurrent) urinary tract infections (UTIs) in women. A secondary claim
was approved to help prevent (recurrent) urinary tract infections, which
may increase in frequency/incidence after/as a result of menopause in
women.
About Graminex® L.L.C.
Graminex® L.L.C. is the leading producer of natural and
solvent free Graminex® Flower Pollen Extract™. Graminex®
directly owns and manages more than 6,500 acres of farmland in Northwest
Ohio to meet its customer’s needs. Graminex’s® active
ingredients are grown and processed for the dietary supplement,
nutraceutical, pharmaceutical, food and skin care industries. Graminex®
markets its own line of dietary supplements, focusing on prostate care,
urinary care, menopausal support, and skin care. Partnered with its
distributors, retailers and manufacturers, Graminex®
non-solvent products are sold in more than 44 countries on six
continents.
For further information please contact Graminex® L.L.C.
Public Relations, Colleen May at (419) 278-1023 or by e-mail at info@graminex.com.
You may also visit www.graminex.com.
Contacts
Colleen E. May
Public Relations
2-300 County Road C
Deshler,
Ohio 43516
(419) 278-1023
or
Justin E. Ritter
Regulatory
Affairs
2-300 County Road C
Deshler, Ohio 43516
(419)
278-1023